The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

J.J. Lammerts van Bueren; W.K. Bleeker; A. Brännström; A. Von Euler; M. Jansson; M. Peipp; T. Schneider-Merck; T. Valerius; J.G.J. van de Winkel; P.W.H.I. Parren

The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

Translated title of the contribution: The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

J.J. Lammerts van Bueren, W.K. Bleeker, A. Brännström, A. Von Euler, M. Jansson, M. Peipp, T. Schneider-Merck, T. Valerius, J.G.J. van de Winkel, P.W.H.I. Parren

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Translated title of the contribution	The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
Original language	Undefined/Unknown
Pages (from-to)	6109-6114
Number of pages	6
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	105
Issue number	16
Publication status	Published - 2008

Access to Document

JvdW The antibody zalutumumab
Open Access (free)

Cite this

Lammerts van Bueren, J. J., Bleeker, W. K., Brännström, A., Von Euler, A., Jansson, M., Peipp, M., Schneider-Merck, T., Valerius, T., van de Winkel, J. G. J., & Parren, P. W. H. I. (2008). The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility. Proceedings of the National Academy of Sciences of the United States of America, 105(16), 6109-6114.

@article{c74398edbc014c31a54853ac44a95795,

title = "The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.",

author = "\{Lammerts van Bueren\}, J.J. and W.K. Bleeker and A. Br{\"a}nnstr{\"o}m and \{Von Euler\}, A. and M. Jansson and M. Peipp and T. Schneider-Merck and T. Valerius and \{van de Winkel\}, J.G.J. and P.W.H.I. Parren",

year = "2008",

language = "Undefined/Unknown",

volume = "105",

pages = "6109--6114",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "16",

}

Lammerts van Bueren, JJ, Bleeker, WK, Brännström, A, Von Euler, A, Jansson, M, Peipp, M, Schneider-Merck, T, Valerius, T, van de Winkel, JGJ & Parren, PWHI 2008, 'The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.', Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 16, pp. 6109-6114.

The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility. / Lammerts van Bueren, J.J.; Bleeker, W.K.; Brännström, A. et al.
In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 16, 2008, p. 6109-6114.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

AU - Lammerts van Bueren, J.J.

AU - Bleeker, W.K.

AU - Brännström, A.

AU - Von Euler, A.

AU - Jansson, M.

AU - Peipp, M.

AU - Schneider-Merck, T.

AU - Valerius, T.

AU - van de Winkel, J.G.J.

AU - Parren, P.W.H.I.

PY - 2008

Y1 - 2008

M3 - Article

SN - 0027-8424

VL - 105

SP - 6109

EP - 6114

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 16

ER -